US Business

Companies trying to break the grip on rare-earth magnets—a crucial ingredient in modern technology—are encountering unusual hurdles.

The drugmaker is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales.

Federal judge in San Francisco likely to order billionaire’s cooperation with agency’s probe into his 2022 takeover of Twitter.

The move is the latest twist in a high-profile proxy battle between Peltz’s Trian Fund Management and the entertainment giant.

Drugmakers and distributors pledged tens of billions of dollars to settle lawsuits accusing them of helping fuel the country’s opioid crisis. But much of the money may never be paid.

The experiment was meant to boost fan engagement and set up media-rights deals.

Netflix released its first engagement report, revealing the viewership of its top programming through the first six months of the year.

U.S. auto-safety regulators are looking into crashes involving the driver-assistance technology.

Technology giants led the way, with Apple, Nvidia, Alphabet and IBM rounding out the top 5

The company plans to add Stolen Device Protection in a future iOS update following a yearlong WSJ investigation.